Mariner Wealth Advisors »

Urogen Pharma shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $281k 7.6k 36.80

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Broadcom (AVGO)
Ishares Tr Core S&p Mcp Etf (IJH)
Micron Technology (MU)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Mariner Wealth Advisors

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
SG Americas Securities
American Century Companies
Acorn Capital Advisors
Point72 Asset Management
Frontier Capital Management
Opaleye Management
Silverarc Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co
MPM Oncology Impact Management

View all funds holding Urogen Pharma